Biomarin Pharma

VIMIZIM

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / VIMIZIM – J1322

Manufacturer:

Biomarin Pharma

Name:

VIMIZIM

HCPCS Code Descriptor:

Injection, elosulfase alfa, 1 mg

Category:

J Code

HCPCS:

J1322

NDC(s):

68135-0100-01

Primary Type:

Enzyme Replacement Therapy

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

VIMIZIM is an Enzyme Replacement Therapy drug manufactured by Biomarin Pharma and administered via the Intravenous route of administration. The J Code: J1322 is aligned to the drug VIMIZIM.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/15

HCPCS Effective Date:

1/1/15

HCPCS Short Description:

Elosulfase alfa, injection

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.biomarin-rareconnections.com/